Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

Cheung, TT; Mai, TH; Chia, YL; Yap, DY; Lee, CH; Chen, CCK; Huang, Y; Jin, YW; Johnston, J; Werkstroem, V; Yao, YH; Ge, XY; Zheng, WY

Chia, YL (通讯作者),AstraZeneca, BioPharmaceut R&D, Clin Pharmacol & Safety Sci, Clin Pharmacol & Quantitat Pharmacol, 701 Gateway Blvd, South San Francisco, CA 94080 USA.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2023; 17 (): 209